Browse > Article
http://dx.doi.org/10.14476/jomp.2012.37.4.189

Oral Pigmentation Resulting from Pharmacological Treatment in Patient with Chronic Hepatitis C  

Kim, Young Gun (Department of Orofacial Pain and Oral Medicine, Yonsei Dental Hospital, Yonsei University College of Dentistry)
Ahn, Hyung-Joon (Department of Orofacial Pain and Oral Medicine, Yonsei Dental Hospital, Yonsei University College of Dentistry)
Choi, Jong-Hoon (Department of Orofacial Pain and Oral Medicine, Yonsei Dental Hospital, Yonsei University College of Dentistry)
Kwon, Jeong-Seung (Department of Orofacial Pain and Oral Medicine, Yonsei Dental Hospital, Yonsei University College of Dentistry)
Publication Information
Journal of Oral Medicine and Pain / v.37, no.4, 2012 , pp. 189-193 More about this Journal
Abstract
Oral pigmentation has numerous etiologies. It can be associated with congenital diseases and syndromes, certain acquired diseases, and systemic medications. Pigmented lesions caused by serious disease such as melanoma should be diagnosed correctly, because it would be fatal. For appropriate differential diagnosis, clinicians should know about the etiologies causing oral pigmentation and take patients history carefully. Biopsies would be necessary for histopathological findings. Close follow up for clinical symptoms are also necessary. In this case report, we presented a case of oral hyperpigmentation in Asian patient who was receiving pegylated interferon and ribavirin combination therapy for hepatitis C virus infection.
Keywords
Hepatitis C virus; Oral hyperpigmentation; Interferon; Ribavirin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S. Muller, Melanin-Associated Pigmented Lesions of the Oral Mucosa: Presentation, Differential Diagnosis, and Treatment. Dermatol Ther, 2010 ; 23 : 220-9.   DOI   ScienceOn
2 2011 European Association of the Study of the Liver Hepatitis C Virus Clinical Practice Guidelines, Liver Int, 2012 ; 32 Suppl 1 : 2-8.
3 M. Willems, K. Munte, J. M. Vrolijk et al. Hyperpigmentation During Interferon-Alpha Therapy for Chronic Hepatitis C Virus Infection. Br J Dermatol, 2003 ; 149 : 390-4.   DOI   ScienceOn
4 P. C. de Moraes, C. W. Noce, L. A. Thomaz et al. Tongue Hyperpigmentation Resulting from Peginterferon Alfa and Ribavirin Combination Therapy: A Case Report. J Am Dent Assoc, 2009; 140 : 1377-9.   DOI   ScienceOn
5 D. Farshidi, and M. W. Chiu, Lingual Hyperpigmentation from Pegylated Interferon and Ribavirin Treatment of Hepatitis C. J Am Acad Dermatol, 2010 ; 62 : 164-5.   DOI   ScienceOn
6 A. Fernandez, S. Vazquez, and L. Rodriguez- Gonzalez, Tongue Hyperpigmentation Resulting from Peginterferon Alpha-2a and Ribavirin Treatment in a Caucasian Patient with Chronic Hepatitis C. J Eur Acad Dermatol Venereol, 2009 ; 22 : 1389-91.
7 S. Ghosh, A. Duseja, R. K. Dhiman, and Y. K. Chawla, Tongue Hyperpigmentation Resulting from Peginterferon Alfa-2b and Ribavirin Treatment in a Patient with Chronic Hepatitis C. Dig Dis Sci 2012 ; 57 : 820-1.   DOI   ScienceOn
8 C. Gurguta, C. Kauer, U. Bergholz et al Tongue and Skin Hyperpigmentation During Peg-Interferon -Alpha/Ribavirin Therapy in Dark-Skinned Non- Caucasian Patients with Chronic Hepatitis C. Am J Gastroenterol, 2006 ; 101 : 197-8.   DOI   ScienceOn
9 O. Karabay, N. Goksugur, and A. Ogutlu, Tongue Hyperpigmentation During Interferon Therapy, J Dermatol, 2011 ; 38 : 290-1.   DOI   ScienceOn
10 Y. Radha Krishna, and S. Itha, What Caused This Lingual Hyperpigmentation in a Patient with Chronic Hepatitis C?, Liver Int, 2010 ; 30 : 416.   DOI   ScienceOn
11 H. A. Torres, L. Bull, R. C. Arduino et al. Tongue Hyperpigmentation in a Caucasian Patient Coinfected with HIV and Hepatitis C During Peginterferon Alfa-2b and Ribavirin Therapy, Am J Gastroenterol, 2007 ; 102 : 1334-5.   DOI   ScienceOn